|
|
Evogene Ltd
TLV •
Healthcare •
Biotechnology •
Quote as of 07/10/2026 13:44
Company Profile
IndustryBiotechnology
SectorHealthcare
ExchangeTLV
Market Capitalization14.61 mln
Float10.33 mln
Earnings Date08/19/2026
Key Fundamentals
EPS-5.05
ROE-172
RPS1.57
ROIC-101
ROA-32.06
EBITDA, mln-35.42
EV / EBITDA-0.72
EV / EBIT-0.66
Revenue, mln11.19
EV / Revenue2.28
Financial Strength
Altman Z-Score-20.45
Piotroski F-Score
2
/ 9
Beneish M-Score-8.01
Price Performance & Relative Strength
| Period |
Price Performance |
Relative Strength |
| 1 Week |
9.68% |
98
/ 100
 |
| 1 Month |
-17.3% |
4
/ 100
 |
| 2 Months |
-44.25% |
3
/ 100
|
| 6 Months |
-57.4% |
2
/ 100
|
| 1 Year |
-70.23% |
2
/ 100
|
|
| |
